Multinational drug firms increase market share

With foreign drug makers taking a bigger share of the domestic prescription market and mid-tier companies facing restructuring, Korea's pharmaceutical industry is expecting major changes.

According to the data compiled by securities firms, the domestic ethical market for outpatients in June accounted for 671.5 billion won, showing a 10.1-percent decrease over the same period of last year and...